A study to assess the effect of AZD5055 on the pharmacokinetics (PK) of Nintedanib in healthy participants.

Trial Identifier:	D8960C00003
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT05644600
Start Date:	May 2023
Primary Completion Date:	July 2023
Study Completion Date:	July 2023
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Glendale, GB, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.